Topical Ruxolitinib Therapeutic Cheat Sheet
Ruxolitinib (OPZELURA) is a twice daily topical cream that is FDA approved for non-segmental vitiligo and mild to moderate atopic dermatitis1. JAK inhibitors are a class of drugs effective in treating a wide variety of inflammatory conditions. Initially only FDA approved for non-dermatologic conditions such as rheumatoid arthritis and ulcerative colitis, there is now strong evidence that JAK/STAT …
Ruxolitinib (OPZELURA) is a twice daily topical cream that is FDA approved for non-segmental vitiligo and mild to moderate atopic dermatitis1. JAK inhibitors are a class of drugs effective in treating a wide variety of inflammatory conditions. Initially only FDA approved for non-dermatologic conditions such as rheumatoid arthritis and ulcerative colitis, there is now strong evidence that JAK/STAT … Continue reading "Topical Ruxolitinib Therapeutic Cheat Sheet"
Following numerous office-based dermatologic procedures, erythema, swelling, and scarring are often feared complications experienced by our patients. Understanding the wound healing response is synonymous with understanding the stages of healing and ultimately the clinical appearance of each wound. Possessing and sharing a firm grasp on this knowledge allows for patient empowerment during the woun … 
Dr. Michael J. Visconti continues our Therapeutic Cheat Sheet series, surgical edition, with a look at the bilobed flap, one of the workhorse reconstructive designs in the armamentarium of dermatologic surgeons.
The Bilobed Flap Therapeutic Cheat Sheet
Compiled by: Michael J. Visconti, DO |Reviewed by: Vishal A. Patel, MD
Background
Vascular Supply: random pattern
Movement Class … 
At its core, dermabrasion is the application of an abrasive surface to the skin with the goal of inciting cutaneous injury to subsequently induce a healing response. This relationship is utilized in dermabrasion to promote improved complexion, contour, and appearance of the skin in the treatment of acne scarring, surgical scarring, destruction of benign cutaneous lesions, as well as a secondary re … 
Intravenous immune globulin (IVIG) is a concentrate of pooled immunoglobulins derived from plasma donors. Its unique mechanism of action expands the utility of the medication to a variety of conditions. We continue our series, Therapeutic Cheat Sheet, with a closer look at IVIG, which is FDA-approved for the treatment of dermatologic conditions including dermatomyositis, Kawasaki disease, ITP, and … 